The funding will support growth outside of Mumbai over the next two years, leveraging India’s rapidly growing fertility services market. | Photo Credits:
Luma Fertility is a technology-enabled fertility startup by serial entrepreneur Neha K Motwani, raising $4 million in seed funds led by Peak XV’s Surge. According to a startup memo, Metropolis Healthcare’s Amirashah is investing in personal abilities in addition to Vijay Taparia (B2V Ventures).
The funding will help Luma expand his footprint in Mumbai and other cities in the future over the next two years.
Luma Fertility was born from Neha’s personal fertility journey, as Neha Motwani had previously built Fitternity (India’s largest fitness marketplace – later acquired by Curefit). “From my own experience and after talking to hundreds of women, it became clear that Indian fertility care is broken. It’s optimized for the system, not the people. At Ruma, we rebuilt it from scratch. It was completely designed around the patients.”
Ameera Shah, promoter and executive chairperson of Metropolis Healthcare, said, “India’s fertility treatment is at an inflection point. Demand is rapidly increasing, but the system is deeply fragmented and outdated.
The flagship clinic is located in Bandra, Mumbai and features an in-house lab that performs all infertility procedures. “The clinic offers services such as IVF, egg and embryo freeze, fertility assessment, and preconcept consultation. Luma also offers at-home semen analysis, personalized reports and overall services that improve outcomes such as nutrition, acupuncture, IV drip, and one-on-one sessions.”
The global fertility services market is projected to reach $53 billion by 2030, according to the memo, which states that there are trends such as delayed parent-child relationships, increased age-related infertility and reduced global fertility. He also noted that in India, total fertility rates have fallen below the alternative level, dropping from 2.1 to 1.9 births per woman. In India, more than 33 million couples face fertility issues, with IVF cycles expected to reach 550K in 2028 from 320K in 2024. “Given the evolving Indian economy and the increased per capita income, there is potential demand for transparency, patient-centric and technology-ready IVF and fertility preservation services, such as egg freezing and embryo freezing.”
Released on July 4, 2025
